AO Annual Report 2020
17 June 2021
The AO Annual Report 2020, now available online, looks at the challenges and achievements of a year out of the ordinary across five separate chapters—education, innovation, research, finance and governance, and corporate social responsibility—and ARI milestones played an important role.
Against the backdrop of the COVID-19 pandemic, ARI contributed significantly to an extraordinary 2020 for the AO, with a new record high of 116 publications and a notable increase in its publications’ average impact factor.
In parallel, ARI licensed its groundbreaking tissue engineering technology, Sound-Wave Induced Morphogenesis (3D SIM), to the newly created mimiX biotherapeutics from Switzerland. SIM is a gentle, fast, and easy method used to generate multi-cellular, spatially orchestrated tissue constructs using sound waves.
ARI research with impact
ARI is recognized as a research leader in Switzerland, Europe, and the rest of the world. ARI's purpose is advancing patient care through innovative orthopedic research and development. In the AO Annual Report 2020, you can explore a selection of ARI's notable research published in 2020.